This role drives the end-to-end launch strategy and execution for priority vaccine assets from late-stage development through post-launch acceleration.
Base: $231,988.80 - $347,983.20 USD; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program available; Benefits: 401(k), paid vacation/holidays, leaves, medical/dental/vision coverage
Must-have
Nice-to-have
Not specified